Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: A review of the literature

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 4, 2005, Pages 319-322

  Carcaterrra, Maurizio ^a   Osti, Mattia Falchetto ^a   De Sanctis, Vitaliana ^a   Caruso, Cristina ^a   Berardi, Francesca ^a   Enrici, Riccardo Maurizi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adjuvant therapy; Chemoradiation; Esophageal cancer; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; HUMAN; POSTOPERATIVE CARE; RADIATION DOSE; REVIEW;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 33745319056     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. PAKKER SL, TONG T, BOLDEN S, WINGO PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5-27
2. ZEIREN HU, MÜLLER JM, JACOBI CA, PICHLMAIER H, MÜLLER RP, STARR S. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995; 19: 444-449.
3. TENIERE P, HAY JM, FINGERHUT A, FAGNIEZ PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 1991; 173: 123-130.
4. FOK M, SHAM JS, CHOY D, CHENG SW, WONG J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomised controlled study. Surgery 1993; 113: 138-147.
5. FOK M, MCSHANE J, LAW SY, WONG J. A prospective randomised study on radiotherapy and surgery in the treatment of oesophageal carcinoma. Symposium on oesophageal carcinoma in the Asian-Paci.crim. Asian J Surg 1994; 17: 223-229.
6. XIAO ZF, YANG ZY, LIANG J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75: 331-336.
7. XIAO ZF, YANG ZY, Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases Int J Radiat Oncol Biol Phys 2005; 62: 82-90.
8. RICE TW, BLACKSTONE EH, GOLDBLUM JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg. 2001;122:1077-1090.
9. JS MACDONALD, SR SMALLEY Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 2001; 345.
10. BEDARD EL, INCULET RI, MALTHANER RA, BRECEVIC E, VINCENT M, DAR R. The role of surgery and post-operative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001; 91: 2423-2430.
11. RICE T.W. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma J Thor Card Surg 2003
12. M. TACHIBANA, H. YOSHIMURA. Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial EJSO 2003; 29: 580-587.
13. XUE-HUI SHI, WEIQIANG YAO. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999; 51: 21-26.